Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 23,413-23,424 of 23,847
Drug study icon
CompletedNCT00492349

Varenicline Adjunctive Treatment in Schizophrenia

This study exists to explore whether smoking support or smoking-related treatment could improve care and understanding. Researchers are trying to understand whether smoking support or smoking-related treatment can improve attention, thinking, or day-to-day functioning.

In Baltimore
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
University of Maryland, Baltimore
Condition
Schizophrenia
Drug study icon
CompletedNCT04167306

Varenicline and Bupropion for Addiction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Malmö
AddictionDrugFrom 25 Years to 70 Years
Countries
Sweden
Sponsor
Vastra Gotaland Region
Condition
Addiction
Drug study icon
CompletedNCT02271919

Varenicline and Combined NRT for Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Houston
AddictionDrugFrom 18 Years to 75 Years
Countries
United States
Sponsor
M.D. Anderson Cancer Center
Condition
Addiction
Other study type icon
CompletedNCT01111149

Varenicline and Smoking Cessation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Minneapolis
SchizophreniaOtherFrom 18 Years to 75 Years
Countries
United States
Sponsor
University of Minnesota
Condition
Schizophrenia
Drug study icon
CompletedNCT00548470

Varenicline Effects In Schizophrenic Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In New York
Addiction, SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Addiction, Schizophrenia
Drug study icon
CompletedNCT01509547

Varenicline for Adolescent Smoking Cessation

This summary needs review. Please check the official study record and contact the research team for details.

In Charleston
AddictionDrugFrom 14 Years to 21 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Addiction
Drug study icon
CompletedNCT01639560

Varenicline for Light Smokers

This summary needs review. Please check the official study record and contact the research team for details.

In Rochester
AddictionDrugOver 18 Years
Countries
United States
Sponsor
Mayo Clinic
Condition
Addiction
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.